A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients

Fadl Elmula M Fadl Elmula, Paola Rebora, Anneli Talvik, Sabrina Salerno, Eliza Miszkowska-Nagórna, Xiaoqiu Liu, Marika Heinpalu-Kuum, Tommaso Comotti, Anne C. Larstorp, Morten Rostrup, Ewa ͆wierblewska, Maria Grazia Valsecchi, Sverre E. Kjeldsen, Margus Viigimaa, Krzysztof Narkiewicz, Gianfranco Parati, Stéphane Laurent

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: In the BEtter control of BP in hypertensive pAtients monitored Using the HOTMAN sYstem study, we investigated whether utilizing noninvasive monitoring of hemodynamic parameters combined with a drug selection algorithm (integrated hemodynamic management-IHM) compared with conventional drug selection may improve uncontrolled hypertension in European Hypertension Excellence centers. Method: Uncontrolled (office SBP >140 mmHg and ambulatory daytime SBP >135 mmHg while taking-2 antihypertensive drugs) essential hypertensive patients were referred to five European Hypertension Excellence centers and, if eligible, were randomized to IHM-guided (n=83) vs. conventional (control, n=84) treatment adjustment in an investigator-initiated multicenter prospective randomized parallel groups controlled study. Results: The average number of antihypertensive drugs increased from 3.1 to 4.1 in both groups and differed only in a rise of the use of diuretics in the IHM groups (from 13 to 31%). Daytime SBP, defined as the primary endpoint, decreased markedly and to the same extent from baseline to 6 months in IHM (-15.8±14.8 mmHg) and control (-15.4±14.5 mmHg) groups (P=0.87), with a similar behavior of office SBP (no between group differences, P=0.18). Average number of adverse events was significantly lower in IHM than in controls (P=0.008) but of the more general type and not necessarily related to drug treatment. Conclusion: Thus, noninvasive hemodynamic monitoring associated with a drug selection algorithm induced similar reductions in ambulatory daytime and office SBP compared with conventional drug selection in uncontrolled hypertensive patients referred to European Hypertension Excellence centers.

Original languageEnglish
Pages (from-to)2534-2545
Number of pages12
JournalJournal of Hypertension
Volume33
Issue number12
DOIs
Publication statusPublished - 2015

Fingerprint

Hypertension
Pharmaceutical Preparations
Hemodynamics
Antihypertensive Agents
Therapeutics
Diuretics
Research Personnel

Keywords

  • ambulatory blood pressure monitoring
  • antihypertensive drugs
  • blood pressure control
  • integrated hemodynamic monitoring
  • uncontrolled hypertension

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Elmula, F. E. M. F., Rebora, P., Talvik, A., Salerno, S., Miszkowska-Nagórna, E., Liu, X., ... Laurent, S. (2015). A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients. Journal of Hypertension, 33(12), 2534-2545. https://doi.org/10.1097/HJH.0000000000000749

A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients. / Elmula, Fadl Elmula M Fadl; Rebora, Paola; Talvik, Anneli; Salerno, Sabrina; Miszkowska-Nagórna, Eliza; Liu, Xiaoqiu; Heinpalu-Kuum, Marika; Comotti, Tommaso; Larstorp, Anne C.; Rostrup, Morten; ͆wierblewska, Ewa; Valsecchi, Maria Grazia; Kjeldsen, Sverre E.; Viigimaa, Margus; Narkiewicz, Krzysztof; Parati, Gianfranco; Laurent, Stéphane.

In: Journal of Hypertension, Vol. 33, No. 12, 2015, p. 2534-2545.

Research output: Contribution to journalArticle

Elmula, FEMF, Rebora, P, Talvik, A, Salerno, S, Miszkowska-Nagórna, E, Liu, X, Heinpalu-Kuum, M, Comotti, T, Larstorp, AC, Rostrup, M, ͆wierblewska, E, Valsecchi, MG, Kjeldsen, SE, Viigimaa, M, Narkiewicz, K, Parati, G & Laurent, S 2015, 'A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients', Journal of Hypertension, vol. 33, no. 12, pp. 2534-2545. https://doi.org/10.1097/HJH.0000000000000749
Elmula, Fadl Elmula M Fadl ; Rebora, Paola ; Talvik, Anneli ; Salerno, Sabrina ; Miszkowska-Nagórna, Eliza ; Liu, Xiaoqiu ; Heinpalu-Kuum, Marika ; Comotti, Tommaso ; Larstorp, Anne C. ; Rostrup, Morten ; ͆wierblewska, Ewa ; Valsecchi, Maria Grazia ; Kjeldsen, Sverre E. ; Viigimaa, Margus ; Narkiewicz, Krzysztof ; Parati, Gianfranco ; Laurent, Stéphane. / A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients. In: Journal of Hypertension. 2015 ; Vol. 33, No. 12. pp. 2534-2545.
@article{deb80a885d1a4483a610fe4d87e0adbc,
title = "A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients",
abstract = "Background: In the BEtter control of BP in hypertensive pAtients monitored Using the HOTMAN sYstem study, we investigated whether utilizing noninvasive monitoring of hemodynamic parameters combined with a drug selection algorithm (integrated hemodynamic management-IHM) compared with conventional drug selection may improve uncontrolled hypertension in European Hypertension Excellence centers. Method: Uncontrolled (office SBP >140 mmHg and ambulatory daytime SBP >135 mmHg while taking-2 antihypertensive drugs) essential hypertensive patients were referred to five European Hypertension Excellence centers and, if eligible, were randomized to IHM-guided (n=83) vs. conventional (control, n=84) treatment adjustment in an investigator-initiated multicenter prospective randomized parallel groups controlled study. Results: The average number of antihypertensive drugs increased from 3.1 to 4.1 in both groups and differed only in a rise of the use of diuretics in the IHM groups (from 13 to 31{\%}). Daytime SBP, defined as the primary endpoint, decreased markedly and to the same extent from baseline to 6 months in IHM (-15.8±14.8 mmHg) and control (-15.4±14.5 mmHg) groups (P=0.87), with a similar behavior of office SBP (no between group differences, P=0.18). Average number of adverse events was significantly lower in IHM than in controls (P=0.008) but of the more general type and not necessarily related to drug treatment. Conclusion: Thus, noninvasive hemodynamic monitoring associated with a drug selection algorithm induced similar reductions in ambulatory daytime and office SBP compared with conventional drug selection in uncontrolled hypertensive patients referred to European Hypertension Excellence centers.",
keywords = "ambulatory blood pressure monitoring, antihypertensive drugs, blood pressure control, integrated hemodynamic monitoring, uncontrolled hypertension",
author = "Elmula, {Fadl Elmula M Fadl} and Paola Rebora and Anneli Talvik and Sabrina Salerno and Eliza Miszkowska-Nag{\'o}rna and Xiaoqiu Liu and Marika Heinpalu-Kuum and Tommaso Comotti and Larstorp, {Anne C.} and Morten Rostrup and Ewa ͆wierblewska and Valsecchi, {Maria Grazia} and Kjeldsen, {Sverre E.} and Margus Viigimaa and Krzysztof Narkiewicz and Gianfranco Parati and St{\'e}phane Laurent",
year = "2015",
doi = "10.1097/HJH.0000000000000749",
language = "English",
volume = "33",
pages = "2534--2545",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients

AU - Elmula, Fadl Elmula M Fadl

AU - Rebora, Paola

AU - Talvik, Anneli

AU - Salerno, Sabrina

AU - Miszkowska-Nagórna, Eliza

AU - Liu, Xiaoqiu

AU - Heinpalu-Kuum, Marika

AU - Comotti, Tommaso

AU - Larstorp, Anne C.

AU - Rostrup, Morten

AU - ͆wierblewska, Ewa

AU - Valsecchi, Maria Grazia

AU - Kjeldsen, Sverre E.

AU - Viigimaa, Margus

AU - Narkiewicz, Krzysztof

AU - Parati, Gianfranco

AU - Laurent, Stéphane

PY - 2015

Y1 - 2015

N2 - Background: In the BEtter control of BP in hypertensive pAtients monitored Using the HOTMAN sYstem study, we investigated whether utilizing noninvasive monitoring of hemodynamic parameters combined with a drug selection algorithm (integrated hemodynamic management-IHM) compared with conventional drug selection may improve uncontrolled hypertension in European Hypertension Excellence centers. Method: Uncontrolled (office SBP >140 mmHg and ambulatory daytime SBP >135 mmHg while taking-2 antihypertensive drugs) essential hypertensive patients were referred to five European Hypertension Excellence centers and, if eligible, were randomized to IHM-guided (n=83) vs. conventional (control, n=84) treatment adjustment in an investigator-initiated multicenter prospective randomized parallel groups controlled study. Results: The average number of antihypertensive drugs increased from 3.1 to 4.1 in both groups and differed only in a rise of the use of diuretics in the IHM groups (from 13 to 31%). Daytime SBP, defined as the primary endpoint, decreased markedly and to the same extent from baseline to 6 months in IHM (-15.8±14.8 mmHg) and control (-15.4±14.5 mmHg) groups (P=0.87), with a similar behavior of office SBP (no between group differences, P=0.18). Average number of adverse events was significantly lower in IHM than in controls (P=0.008) but of the more general type and not necessarily related to drug treatment. Conclusion: Thus, noninvasive hemodynamic monitoring associated with a drug selection algorithm induced similar reductions in ambulatory daytime and office SBP compared with conventional drug selection in uncontrolled hypertensive patients referred to European Hypertension Excellence centers.

AB - Background: In the BEtter control of BP in hypertensive pAtients monitored Using the HOTMAN sYstem study, we investigated whether utilizing noninvasive monitoring of hemodynamic parameters combined with a drug selection algorithm (integrated hemodynamic management-IHM) compared with conventional drug selection may improve uncontrolled hypertension in European Hypertension Excellence centers. Method: Uncontrolled (office SBP >140 mmHg and ambulatory daytime SBP >135 mmHg while taking-2 antihypertensive drugs) essential hypertensive patients were referred to five European Hypertension Excellence centers and, if eligible, were randomized to IHM-guided (n=83) vs. conventional (control, n=84) treatment adjustment in an investigator-initiated multicenter prospective randomized parallel groups controlled study. Results: The average number of antihypertensive drugs increased from 3.1 to 4.1 in both groups and differed only in a rise of the use of diuretics in the IHM groups (from 13 to 31%). Daytime SBP, defined as the primary endpoint, decreased markedly and to the same extent from baseline to 6 months in IHM (-15.8±14.8 mmHg) and control (-15.4±14.5 mmHg) groups (P=0.87), with a similar behavior of office SBP (no between group differences, P=0.18). Average number of adverse events was significantly lower in IHM than in controls (P=0.008) but of the more general type and not necessarily related to drug treatment. Conclusion: Thus, noninvasive hemodynamic monitoring associated with a drug selection algorithm induced similar reductions in ambulatory daytime and office SBP compared with conventional drug selection in uncontrolled hypertensive patients referred to European Hypertension Excellence centers.

KW - ambulatory blood pressure monitoring

KW - antihypertensive drugs

KW - blood pressure control

KW - integrated hemodynamic monitoring

KW - uncontrolled hypertension

UR - http://www.scopus.com/inward/record.url?scp=84947042341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947042341&partnerID=8YFLogxK

U2 - 10.1097/HJH.0000000000000749

DO - 10.1097/HJH.0000000000000749

M3 - Article

VL - 33

SP - 2534

EP - 2545

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 12

ER -